Skip to main content

Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency.

Publication ,  Journal Article
Burrage, LC; Madan, S; Li, X; Ali, S; Mohammad, M; Stroup, BM; Jiang, M-M; Cela, R; Bertin, T; Jin, Z; Dai, J; Guffey, D; Finegold, M ...
Published in: JCI Insight
February 27, 2020

BACKGROUNDLiver disease in urea cycle disorders (UCDs) ranges from hepatomegaly and chronic hepatocellular injury to cirrhosis and end-stage liver disease. However, the prevalence and underlying mechanisms are unclear.METHODSWe estimated the prevalence of chronic hepatocellular injury in UCDs using data from a multicenter, longitudinal, natural history study. We also used ultrasound with shear wave elastography and FibroTest to evaluate liver stiffness and markers of fibrosis in individuals with argininosuccinate lyase deficiency (ASLD), a disorder with high prevalence of elevated serum alanine aminotransferase (ALT). To understand the human observations, we evaluated the hepatic phenotype of the AslNeo/Neo mouse model of ASLD.RESULTSWe demonstrate a high prevalence of elevated ALT in ASLD (37%). Hyperammonemia and use of nitrogen-scavenging agents, 2 markers of disease severity, were significantly (P < 0.001 and P = 0.001, respectively) associated with elevated ALT in ASLD. In addition, ultrasound with shear wave elastography and FibroTest revealed increased echogenicity and liver stiffness, even in individuals with ASLD and normal aminotransferases. The AslNeo/Neo mice mimic the human disorder with hepatomegaly, elevated aminotransferases, and excessive hepatic glycogen noted before death (3-5 weeks of age). This excessive hepatic glycogen is associated with impaired hepatic glycogenolysis and decreased glycogen phosphorylase and is rescued with helper-dependent adenovirus expressing Asl using a liver-specific (ApoE) promoter.CONCLUSIONOur results link urea cycle dysfunction and impaired hepatic glucose metabolism and identify a mouse model of liver disease in the setting of urea cycle dysfunction.TRIAL REGISTRATIONThis study has been registered at ClinicalTrials.gov (NCT03721367, NCT00237315).FUNDINGFunding was provided by NIH, Burroughs Wellcome Fund, NUCDF, Genzyme/ACMG Foundation, and CPRIT.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JCI Insight

DOI

EISSN

2379-3708

Publication Date

February 27, 2020

Volume

5

Issue

4

Location

United States

Related Subject Headings

  • Urea Cycle Disorders, Inborn
  • Mice
  • Longitudinal Studies
  • Liver Glycogen
  • Liver Diseases
  • Humans
  • Disease Models, Animal
  • Chronic Disease
  • Argininosuccinate Lyase
  • Animals
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Burrage, L. C., Madan, S., Li, X., Ali, S., Mohammad, M., Stroup, B. M., … Lee, B. (2020). Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency. JCI Insight, 5(4). https://doi.org/10.1172/jci.insight.132342
Burrage, Lindsay C., Simran Madan, Xiaohui Li, Saima Ali, Mahmoud Mohammad, Bridget M. Stroup, Ming-Ming Jiang, et al. “Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency.JCI Insight 5, no. 4 (February 27, 2020). https://doi.org/10.1172/jci.insight.132342.
Burrage LC, Madan S, Li X, Ali S, Mohammad M, Stroup BM, et al. Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency. JCI Insight. 2020 Feb 27;5(4).
Burrage, Lindsay C., et al. “Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency.JCI Insight, vol. 5, no. 4, Feb. 2020. Pubmed, doi:10.1172/jci.insight.132342.
Burrage LC, Madan S, Li X, Ali S, Mohammad M, Stroup BM, Jiang M-M, Cela R, Bertin T, Jin Z, Dai J, Guffey D, Finegold M, Members of the Urea Cycle Disorders Consortium (UCDC), Nagamani S, Minard CG, Marini J, Masand P, Schady D, Shneider BL, Leung DH, Bali D, Lee B. Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency. JCI Insight. 2020 Feb 27;5(4).

Published In

JCI Insight

DOI

EISSN

2379-3708

Publication Date

February 27, 2020

Volume

5

Issue

4

Location

United States

Related Subject Headings

  • Urea Cycle Disorders, Inborn
  • Mice
  • Longitudinal Studies
  • Liver Glycogen
  • Liver Diseases
  • Humans
  • Disease Models, Animal
  • Chronic Disease
  • Argininosuccinate Lyase
  • Animals